AMEX:CLDI (USA)
Â
Ordinary Shares
$
0.73
-0.014 (-1.92%)
07:08 PM EST
Warning! GuruFocus detected
1 Severe warning sign
with CLDI.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Calidi Biotherapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US3207031010
Share Class Description:
CLDI: Ordinary SharesDescription
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | -1.55 | |||||
| Debt-to-Equity | -0.88 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -95.5 | |||||
| 3-Year EPS without NRI Growth Rate | -106.3 | |||||
| 3-Year FCF Growth Rate | -124.5 | |||||
| 3-Year Book Growth Rate | 28.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 70.37 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.95 | |||||
| 9-Day RSI | 35.09 | |||||
| 14-Day RSI | 38.9 | |||||
| 3-1 Month Momentum % | -33.03 | |||||
| 6-1 Month Momentum % | -17.71 | |||||
| 12-1 Month Momentum % | -83.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.19 | |||||
| Quick Ratio | 0.19 | |||||
| Cash Ratio | 0.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.4 | |||||
| Shareholder Yield % | 3.94 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -267.57 | |||||
| ROIC % | -239.7 | |||||
| 3-Year ROIIC % | 24799.57 | |||||
| ROC (Joel Greenblatt) % | -514.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.06 | |||||
| EV-to-Forward-EBIT | -0.83 | |||||
| EV-to-EBITDA | -1.13 | |||||
| EV-to-FCF | -1.44 | |||||
| Earnings Yield (Greenblatt) % | -94.34 | |||||
| FCF Yield % | -103.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:CLDI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Calidi Biotherapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -18.967 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 126.37 | ||
| 14-Day RSI | 38.9 | ||
| 14-Day ATR ($) | 0.110619 | ||
| 20-Day SMA ($) | 0.828525 | ||
| 12-1 Month Momentum % | -83.26 | ||
| 52-Week Range ($) | 0.58 - 8.3 | ||
| Shares Outstanding (Mil) | 25.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Calidi Biotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Calidi Biotherapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Calidi Biotherapeutics Inc Frequently Asked Questions
What is Calidi Biotherapeutics Inc(CLDI)'s stock price today?
The current price of CLDI is $0.73. The 52 week high of CLDI is $8.30 and 52 week low is $0.58.
When is next earnings date of Calidi Biotherapeutics Inc(CLDI)?
The next earnings date of Calidi Biotherapeutics Inc(CLDI) is 2025-05-14 Est..
Does Calidi Biotherapeutics Inc(CLDI) pay dividends? If so, how much?
Calidi Biotherapeutics Inc(CLDI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers